Jyoti Malhotra Selected Research

Jyoti Malhotra Research Topics

Disease

37	Neoplasms (Cancer) 03/2024 - 04/2011
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 04/2016
10	Lung Neoplasms (Lung Cancer) 10/2023 - 12/2015
4	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2024 - 01/2021
3	Pneumonia (Pneumonitis) 05/2023 - 01/2020
2	Adenocarcinoma of Lung 10/2023 - 03/2022
2	Melanoma (Melanoma, Malignant) 07/2022 - 10/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 05/2021
2	Human Influenza (Influenza) 01/2022 - 01/2020
2	Diarrhea 05/2021 - 10/2019
2	Disease Progression 05/2021 - 01/2021
2	Infections 03/2021 - 01/2020
2	Inflammation (Inflammations) 03/2021 - 11/2019
2	Carcinogenesis 10/2016 - 03/2015
2	Breast Neoplasms (Breast Cancer) 12/2015 - 07/2014
1	Radiation Pneumonitis 05/2023
1	Neuromuscular Diseases (Neuromuscular Disease) 01/2023
1	Hepatocellular Carcinoma (Hepatoma) 12/2022
1	Hemophilia A (Haemophilia) 12/2022
1	Clinical Deterioration 01/2022
1	COVID-19 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Testicular Neoplasms (Testicular Cancer) 11/2021
1	Anemia 05/2021
1	Dyspnea (Shortness of Breath) 05/2021
1	Neutropenia 05/2021
1	Hypophosphatemia 05/2021
1	Respiratory Insufficiency (Respiratory Failure) 05/2021
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Headache (Headaches) 01/2021
1	Vomiting 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2015
5	Biomarkers (Surrogate Marker)IBA 06/2023 - 03/2015
4	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 09/2014
3	DystrophinIBA 01/2024 - 01/2021
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023 - 01/2019
3	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 04/2016
3	RNA (Ribonucleic Acid)IBA 03/2021 - 10/2016
2	Riluzole FDA LinkGeneric 10/2023 - 07/2022
2	Immune Checkpoint InhibitorsIBA 05/2023 - 10/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 01/2022
2	pembrolizumabIBA 01/2020 - 04/2017
2	TIC10 compoundIBA 01/2019 - 08/2017
2	Bortezomib (Velcade)FDA Link 06/2014 - 04/2011
1	sotorasibIBA 03/2024
1	adagrasibIBA 03/2024
1	ErbB Receptors (EGF Receptor)IBA 10/2023
1	Tyrosine Kinase InhibitorsIBA 10/2023
1	Programmed Cell Death 1 ReceptorIBA 10/2023
1	NexusIBA 10/2023
1	Sorafenib (BAY 43-9006)FDA Link 10/2023
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 10/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2023
1	trametinibIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2022
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 12/2022
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 12/2022
1	talazoparibIBA 11/2022
1	ProdrugsIBA 07/2022
1	Glutamic Acid (Glutamate)FDA Link 07/2022
1	NivolumabIBA 07/2022
1	Fibrinogen (Factor I)FDA Link 03/2022
1	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2022
1	1- ethyl- 7- (2- methyl- 6- (1H- 1,2,4- triazol- 3- yl)pyridin- 3- yl)- 3,4- dihydropyrazino(2,3- b)pyrazin- 2(1H)- oneIBA 01/2022
1	montelukast (Singulair)FDA Link 01/2022
1	veliparibIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	PlatinumIBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	CytokinesIBA 01/2022
1	Topoisomerase InhibitorsIBA 01/2022
1	AntigensIBA 11/2021
1	Protein Subunit VaccinesIBA 11/2021
1	Glycoproteins (Glycoprotein)IBA 05/2021
1	glembatumumab vedotinIBA 05/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	isochorismataseIBA 03/2021
1	Small Interfering RNA (siRNA)IBA 03/2021
1	navitoclaxIBA 01/2021
1	osimertinibIBA 01/2021
1	eteplirsenIBA 01/2021
1	Antisense OligonucleotidesIBA 01/2021

Therapy/Procedure

18	Therapeutics 10/2023 - 01/2018
8	Immunotherapy 01/2023 - 04/2017
7	Drug Therapy (Chemotherapy) 10/2023 - 12/2012
7	Radiotherapy 05/2023 - 12/2012
3	Aftercare (After-Treatment) 10/2023 - 04/2011
2	Chemoradiotherapy 01/2020 - 04/2016
1	Length of Stay 01/2022